Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study
Enterococcus faecalis infective endocarditis (EFIE) is a severe disease of increasing incidence. The objective was to analyze whether the outcome of patients with native valve EFIE (NVEFIE) treated with a short course of ampicillin plus ceftriaxone (4wAC) was similar to patients treated according to...
| Autores: | , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/176808 |
| Acceso en línea: | https://hdl.handle.net/2445/176808 |
| Access Level: | acceso abierto |
| Palabra clave: | Endocarditis Vàlvules Mortalitat Valves Mortality |
| id |
ES_ca5002c7febda5521c20b597218cd8e2 |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/176808 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort studyRamos Martínez, AntonioPericàs, Juan M.Fernández Cruz, AnaMuñoz, PatriciaValerio, MaricelaKestler, MarthaMontejo, MiguelFariñas, M. CarmenSousa, DoloresDomínguez, FernandoOjeda Burgos, GuillermoPlata, AntonioVidal, LauraMiró Meda, José M. (José María), 1956-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España(GAMES)EndocarditisVàlvulesMortalitatEndocarditisValvesMortalityEnterococcus faecalis infective endocarditis (EFIE) is a severe disease of increasing incidence. The objective was to analyze whether the outcome of patients with native valve EFIE (NVEFIE) treated with a short course of ampicillin plus ceftriaxone (4wAC) was similar to patients treated according to international guidelines (6wAC). Between January 2008 and June 2018, 1,978 consecutive patients with definite native valve IE were prospectively included in a national registry. Outcomes of patients with NVEFIE treated with 4wAC were compared to those of patients who received 6wAC. Three hundred and twenty-two patients (16.3%) had NVEFIE. One hundred and eighty-three (56.8%) received AC. Thirty-nine patients (21.3%) were treated with 4wAC for four weeks and 70 patients (38.3%) with 6wAC. There were no differences in age or comorbidity. Patients treated 6wAC presented a longer duration of symptoms before diagnosis (21 days, IQR 7-60 days vs. 7 days, IQR 1-22 days; p = 0.002). Six patients presented perivalvular abscess and all of these received 6wAC. Surgery was performed on 14 patients (35.9%) 4wAC and 34 patients (48.6%) 6wAC (p = 0.201). In-hospital mortality, one-year mortality and relapses among 4wAC and 6wAC patients were 10.3% vs. 11.4% (p = 0.851); 17.9% vs. 21.4% (p = 0.682) and 5.1% vs. 4.3% (p = 0.833), respectively. In conclusion, a four-week course of AC may be considered as an alternative regimen in NVEFIE, notably in patients with shorter duration of symptoms and those without perivalvular abscess. These results support the performance of a randomized clinical trial to evaluate the efficacy of this short regimen.Public Library of Science (PLoS)2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/176808Articles publicats en revistes (Medicina)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0237011PLoS One, 2020, vol. 15, num. 8, p. e0237011https://doi.org/10.1371/journal.pone.0237011cc-by (c) Ramos Martínez, Antonio et al., 2020http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1768082026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| title |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| spellingShingle |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study Ramos Martínez, Antonio Endocarditis Vàlvules Mortalitat Endocarditis Valves Mortality |
| title_short |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| title_full |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| title_fullStr |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| title_full_unstemmed |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| title_sort |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study |
| dc.creator.none.fl_str_mv |
Ramos Martínez, Antonio Pericàs, Juan M. Fernández Cruz, Ana Muñoz, Patricia Valerio, Maricela Kestler, Martha Montejo, Miguel Fariñas, M. Carmen Sousa, Dolores Domínguez, Fernando Ojeda Burgos, Guillermo Plata, Antonio Vidal, Laura Miró Meda, José M. (José María), 1956- Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España(GAMES) |
| author |
Ramos Martínez, Antonio |
| author_facet |
Ramos Martínez, Antonio Pericàs, Juan M. Fernández Cruz, Ana Muñoz, Patricia Valerio, Maricela Kestler, Martha Montejo, Miguel Fariñas, M. Carmen Sousa, Dolores Domínguez, Fernando Ojeda Burgos, Guillermo Plata, Antonio Vidal, Laura Miró Meda, José M. (José María), 1956- Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España(GAMES) |
| author_role |
author |
| author2 |
Pericàs, Juan M. Fernández Cruz, Ana Muñoz, Patricia Valerio, Maricela Kestler, Martha Montejo, Miguel Fariñas, M. Carmen Sousa, Dolores Domínguez, Fernando Ojeda Burgos, Guillermo Plata, Antonio Vidal, Laura Miró Meda, José M. (José María), 1956- Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España(GAMES) |
| author2_role |
author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Endocarditis Vàlvules Mortalitat Endocarditis Valves Mortality |
| topic |
Endocarditis Vàlvules Mortalitat Endocarditis Valves Mortality |
| description |
Enterococcus faecalis infective endocarditis (EFIE) is a severe disease of increasing incidence. The objective was to analyze whether the outcome of patients with native valve EFIE (NVEFIE) treated with a short course of ampicillin plus ceftriaxone (4wAC) was similar to patients treated according to international guidelines (6wAC). Between January 2008 and June 2018, 1,978 consecutive patients with definite native valve IE were prospectively included in a national registry. Outcomes of patients with NVEFIE treated with 4wAC were compared to those of patients who received 6wAC. Three hundred and twenty-two patients (16.3%) had NVEFIE. One hundred and eighty-three (56.8%) received AC. Thirty-nine patients (21.3%) were treated with 4wAC for four weeks and 70 patients (38.3%) with 6wAC. There were no differences in age or comorbidity. Patients treated 6wAC presented a longer duration of symptoms before diagnosis (21 days, IQR 7-60 days vs. 7 days, IQR 1-22 days; p = 0.002). Six patients presented perivalvular abscess and all of these received 6wAC. Surgery was performed on 14 patients (35.9%) 4wAC and 34 patients (48.6%) 6wAC (p = 0.201). In-hospital mortality, one-year mortality and relapses among 4wAC and 6wAC patients were 10.3% vs. 11.4% (p = 0.851); 17.9% vs. 21.4% (p = 0.682) and 5.1% vs. 4.3% (p = 0.833), respectively. In conclusion, a four-week course of AC may be considered as an alternative regimen in NVEFIE, notably in patients with shorter duration of symptoms and those without perivalvular abscess. These results support the performance of a randomized clinical trial to evaluate the efficacy of this short regimen. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/176808 |
| url |
https://hdl.handle.net/2445/176808 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0237011 PLoS One, 2020, vol. 15, num. 8, p. e0237011 https://doi.org/10.1371/journal.pone.0237011 |
| dc.rights.none.fl_str_mv |
cc-by (c) Ramos Martínez, Antonio et al., 2020 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by (c) Ramos Martínez, Antonio et al., 2020 http://creativecommons.org/licenses/by/3.0/es |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Public Library of Science (PLoS) |
| publisher.none.fl_str_mv |
Public Library of Science (PLoS) |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Medicina) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419468873007104 |
| score |
15.300719 |